Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes-Reference-Cited by-同舟云学术

Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes

Published:2018-07-24 Issue:7 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Dodd Jodie M¹,Grivell Rosalie M²,Deussen Andrea R¹,Hague William M³

Affiliation:

1. The University of Adelaide, Women's and Children's Hospital; School of Paediatrics and Reproductive Health, Discipline of Obstetrics and Gynaecology; 72 King William Road Adelaide South Australia Australia 5006

2. Flinders University and Flinders Medical Centre; Department of Obstetrics and Gynaecology; Bedford Park South Australia Australia SA 5042

3. Women's and Children's Hospital; King William Road Adelaide South Australia Australia SA 5006

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010564.pub2/epdf/full

Reference53 articles.

1. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial;Chiswick;Lancet. Diabetes & Endocrinology,2015

2. Chiswick CA Reynolds RM Denison FC Drake AJ Forbes S Newby DE Does metformin reduce excess birthweight in offspring of obese pregnant women? A randomised controlled trial of efficacy, exploration of mechanisms and evaluation of other pregnancy complications Efficacy and Mechanism Evaluation 2016

3. Efficacy of metformin in pregnant obese women: a randomised controlled trial;Chiswick;BMJ Open,2015

4. EUCTR2009-017134-47-GB Efficacy of metformin in pregnant obese women, a randomised controlled trial (EMPOWaR) clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-017134-47

5. ISRCTN51279843 A multicentre randomised placebo controlled clinical trial of metformin versus placebo in pregnant women to reduce the risk of obesity and metabolic syndrome in their babies isrctn.com/ISRCTN51279843

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin augments major cytoplasmic organization except for spindle organization in oocytes cultured under hyperglycemic and hyperlipidemic conditions: An in vitro study;Toxicology and Applied Pharmacology;2024-09

2. Food, nutrition, and fertility: from soil to fork;The American Journal of Clinical Nutrition;2024-02

3. Antenatale und geburtsmedizinische Komplikationen;Adipositas;2024

4. Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers;World Journal of Diabetes;2023-10-15

5. Efficacy and safety of metformin during pregnancy: an update;Endocrine;2023-10-05